Dose-finding of semaglutide administered subcutaneously once daily versus placebo and liraglutide in subjects with type 2 diabetes

Update Il y a 4 ans
Reference: U1111-1159-4923

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

To compare the efficacy of four (4) dose-levels of semaglutide administered subcutanously (s.c.) once daily (OD) versus placebo on glycaemic control after 26 weeks of treatment


Inclusion criteria

  • Diabetes Mellitus, Type 2